🔗 Share this article

An underground economy for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with numerous of participants share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Express Worries

However, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Some professionals said the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or prison.

Platform Response and Material Removal

Based on the social media company, the platform has taken down problematic content and banned related keywords and query recommendations. The organization stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures.

Online Marketplace Activities

Investigations also discovered communities with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at residence.

After moments of joining one group, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or past usage.

Product Details and Costs

Inside these communities, posts show black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously seen patients injured by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially significant medical dangers”.